Bellin Health, Infectious Diseases, Green Bay; AIDS Resource Center, Green Bay
Infectious Disease
Dr. Michael L. Landrum, MD
|
|
Give Review
Michael Landrum works in the field of Infectious Disease. He researched medicine at University of Missouri-Columbia School of Medicine. Michael Landrum is also published. He has 44 publications published. The lastest publication: "HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.' He accepts all Medicare patients.
Publications
- HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
- Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1-Infected Individuals.
- Delayed-type hypersensitivity and hepatitis B vaccine responses, in vivo markers of cellular and humoral immune function, and the risk of AIDS or death.
- HIV outcomes in Hepatitis B virus coinfected individuals on HAART.
- Reply to Tsai et al.
- Detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus colonization of healthy military personnel by traditional culture, PCR, and mass s...
- Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
- The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: A case-control study.
- Invasive mold infections following combat-related injuries.
- Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010.
- Results of a 25-year longitudinal analysis of the serologic incidence of syphilis in a cohort of HIV-infected patients with unrestricted access to care.
- Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness.
- Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: A rare opportunistic illness.
- Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study.
- Early Post-Seroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1-Postive Subjects Receiving Antiretroviral Therapy.
- The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.
- CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
- The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults.
- The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.
- Prevention and management of infections associated with combat-related thoracic and abdominal cavity injuries.
- Ventilator associated pneumonia in a military deployed setting: the impact of an aggressive infection control program.
- Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid.
- Trimethoprim-sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis.
- Hypertrophic osteoarthropathy associated with metastatic phyllodes tumor.
- Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.
- Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
- Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.
- Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.
- Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.
- Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study.
- Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
- Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.
- A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.
- Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.
- Description of Streptococcus pneumoniae infections in burn patients.
- Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.
- Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?
- The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.
- Syphilis co-infection does not affect HIV disease progression.
- Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS.
- HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
- Race/ethnicity and HAART initiation in a military HIV infected cohort.
- Staphylococcus aureus colonization of healthy military service members in the United States and Afghanistan.
Schools
University Of Missouri Columbia Campus
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
San Antonio Uniformed Services Health Education Consortium -
University of Missouri-Columbia School of Medicine
Drug Facts
| NPI NUMBER | 1932280104 | |
| NPPES Provider LastName | LANDRUM | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 543013505 | |
| NPPES Provider State | WI | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 497.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932280104 |
| Last Name Of The Provider | LANDRUM |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Henry J. Loomans, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adetunji A. Adejumo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Owusu-Bekoe B. Opoku-Owusu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah J. Lulloff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine M. Torres, DO |
|
|
Dr. Anil Chopra, MD |